Sermorelin

Sermoreline (GHRH 1–29) – Growth Hormone Research Peptide

Short Description: Sermoreline (GHRH 1–29) is a synthetic peptide used in research on growth hormone release, pituitary function, and endocrine signaling pathways.

Sermoreline is a synthetic Growth Hormone Releasing Hormone (GHRH) analogue, frequently utilized in biochemical and endocrinological research. In in-vitro settings, it acts on GHRH receptors to stimulate the natural release of Human Growth Hormone (HGH) from the pituitary gland.

This peptide is especially relevant in studies of cell growth, metabolism, and age-related endocrine responses. Each batch is HPLC-verified for ≥99% purity and formulated to support reproducible, controlled laboratory experimentation.

Key Specifications

• Name: Sermoreline (GHRH 1–29)

• Molecular Formula: C149H246N44O42S

• Molecular Weight: ≈3,357 Da

• Form: Lyophilized Powder

• Purity: ≥99% (HPLC tested)

• Storage: Store refrigerated; protect from light and moisture

Research Applications & Benefits

• Studied for its effect on growth hormone secretion and pituitary regulation.

• Essential tool in research exploring GHRH receptor signaling and endocrine pathways.

• Often paired with GHRP-2, Ipamorelin, or similar peptides in comparative research models.

For research use only. Not for human or veterinary use.